Alkion BioInnovations
Created in 2017
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
164 888Activities
Technologies
Entity types
Location
Rte de Saint-Cyr, 78000 Versailles, France
Versailles
France
Employees
Scale: 11-50
Estimated: 12
SIREN
828176784Engaged corporates
4
1 4Added in Motherbase
3 years, 6 months ago
biotech Value proposition
Disruptive solutions to produce high-value plant-based ingredients
Alkion BioInnovations is a pionnier & leader in plant tissue propagation and bioengineering technologies. We have developed and patented a bioproduction platform to obtain high value ingredients (APIs, complex extracts and recombinant proteins) from plant biomass for pharmaceutical & agri-food markets on global and impactful projects.
Through a carbon-neutral approach and using a minimum of resources in optimised bioreactors, our method of production is sustainable, ultra-scalable and cost-efficient.
With our European partners, we develop AI robots to build the world's first industrial in-vitro bioproduction platform, that aims to be flexible and versatile.
Our proprietary project is the large-scale production of the super immunity boosters "QS" for their urgent need, especially in Global South. Derived from Quillaja saponaria tree, QS enhance vaccine efficacy against infectious diseases such as Malaria, TB, HIV, Shigella etc. but also degenerative disorders and certain cancers. Our mission is to revolutionize global vaccine access by providing up to 2 billion doses p.a. at low cost and while preserving biodiversity. We work in collaboration with worldwide NGOs and universities.
A secondary project is the industrial standardised production of cannabinoids, API and extracts, for the therapeutic market (CNS diseases such as Parkinson, MS, neuropathic pain). For this project Alkion owns the first historical R&D licence from French health authorities (2018).
In agrifood, our biosynthesis lab focuses on a healthy sweet protein derived from an exotic plant. It has exceptional physico-chemical properties for industrial applications as healthy sugar alternative in food and pharma products. The project aims at helping farmers increase their revenues while meeting a massive demand.
Alkion is laureate of I-Lab, I-Nov, Plan de Relance, the European Innovation Council Accelerator and is a finalist of Zayed Sustainability Prize in Health category (COP28).
Biotechnologies, Nutrition, Superfood, Natural Additives, Natural Flavors, Natural Ingredients, Agarwood, Natural Sweeteners, Hydroponics 3.0, Bioreactor 3.0, Secondary Metabolims, Essential oils, Cannabinoids, Terpenoids, Biosimilars, Biopharmaceutics, and vaccineadjuvantsOriginal language
Disruptive solutions to produce high-value plant-based ingredients
Alkion BioInnovations is a pionnier & leader in plant tissue propagation and bioengineering technologies. We have developed and patented a bioproduction platform to obtain high value ingredients (APIs, complex extracts and recombinant proteins) from plant biomass for pharmaceutical & agri-food markets on global and impactful projects.
Through a carbon-neutral approach and using a minimum of resources in optimised bioreactors, our method of production is sustainable, ultra-scalable and cost-efficient.
With our European partners, we develop AI robots to build the world's first industrial in-vitro bioproduction platform, that aims to be flexible and versatile.
Our proprietary project is the large-scale production of the super immunity boosters "QS" for their urgent need, especially in Global South. Derived from Quillaja saponaria tree, QS enhance vaccine efficacy against infectious diseases such as Malaria, TB, HIV, Shigella etc. but also degenerative disorders and certain cancers. Our mission is to revolutionize global vaccine access by providing up to 2 billion doses p.a. at low cost and while preserving biodiversity. We work in collaboration with worldwide NGOs and universities.
A secondary project is the industrial standardised production of cannabinoids, API and extracts, for the therapeutic market (CNS diseases such as Parkinson, MS, neuropathic pain). For this project Alkion owns the first historical R&D licence from French health authorities (2018).
In agrifood, our biosynthesis lab focuses on a healthy sweet protein derived from an exotic plant. It has exceptional physico-chemical properties for industrial applications as healthy sugar alternative in food and pharma products. The project aims at helping farmers increase their revenues while meeting a massive demand.
Alkion is laureate of I-Lab, I-Nov, Plan de Relance, the European Innovation Council Accelerator and is a finalist of Zayed Sustainability Prize in Health category (COP28).
Alkion BioInnovations
https://alkinnov.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Not capitalistic Not partnership Event 4 Jul 2019 | | |
 CEA Research | CEA Research | Not capitalistic Not partnership Event 14 Mar 2016 | | |
 AgrOnov Startup accelerator & VC, Farming | AgrOnov Startup accelerator & VC, Farming | Not capitalistic Not partnership Event 16 Apr 2018 | | |
 Eurostat European Union, Environmental Services | Eurostat European Union, Environmental Services | Not capitalistic Not partnership Event 31 May 2022 | | |